CP20 — CJC-1295 10 mg + Ipamorelin 10 mg

Description

CP20 is a dual-compound research blend containing CJC-1295 10 mg and Ipamorelin 10 mg, providing a total of 20 mg of research material.

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been investigated in research involving GHRH receptor activity, growth-hormone signaling and related endocrine pathways.

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS). Experimental research has investigated its activity through growth-hormone-secretagogue receptor pathways and its effects on GH-related signaling.

The combination makes CP20 useful for controlled laboratory investigations examining GHRH-associated and growth-hormone-secretagogue signaling within the same research model. Research literature distinguishes CJC-1295/GHRH analogs from secretagogues such as ipamorelin based on their respective receptor pathways.

CP20 is supplied exclusively for laboratory and scientific research.

Specifications

Product: CP20
Composition: CJC-1295 10 mg + Ipamorelin 10 mg
Total Material: 20 mg
Format: Lyophilized research material
Research Areas: GHRH signaling, growth-hormone-secretagogue signaling, endocrine pathways and receptor-mediated signaling research
Intended Use: Laboratory and scientific research only
COAs: Provided when available

For research use only. Not for human consumption.